Karakoz Tanatkyzy Mukhambetiyar

Ms. Karakoz Tanatkyzy Mukhambetiyar

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2019 in Eurasian Journal of Ecology
Verified
Journal Article
Open access
ALAnna Lovinskaya
Anna Lovinskaya
NBN.T. Bekmagambetova
N.T. Bekmagambetova
AAA.T. Adybayeva
A.T. Adybayeva
KMKarakoz Tanatkyzy Mukhambetiyar
Karakoz Tanatkyzy Mukhambetiyar
SKS.ZH. Kolumbayeva
S.ZH. Kolumbayeva
SASerikbai Karimovich Abilev
Serikbai Karimovich Abilev

Verified
Journal Article
Open access
PDF file
GZGulzhanat Zhunis
Gulzhanat Zhunis
ZBZhandos Burkitbayev
Zhandos Burkitbayev
DBDina Bashayeva
Dina Bashayeva
VKVadim Kemaykin
Vadim Kemaykin
NTNazgul Taskhyngali
Nazgul Taskhyngali
RVRuzal Vildanova
Ruzal Vildanova
Background/Objectives: Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) has expanded donor availability for patients with acute myeloid leukemia; however, it is associated with a high risk of endothelial complications. Among them, sinusoidal obstruction syndrome (SOS) and transplant-associated thrombotic microangiopathy (TA-TMA) are life-threatening conditions with overlapping clinical features, making early diagnosis and management challenging. Case Presentation: We report the case of a 47-year-old woman with acute myeloid leukemia who underwent haploidentical HSCT and developed sequential endothelial complications. On day +11 post-transplant, she presented with weight gain (>5%), hyperbilirubinemia (44 μmol/L), elevated liver enzymes (ALT 2228 U/L and AST 3477 U/L), and multi-organ dysfunction, consistent with probable SOS according to EBMT criteria. Intensive supportive care, glucocorticosteroids, and hemodiafiltration resulted in partial clinical improvement. Subsequently, on day +22, the patient developed progressive thrombocytopenia, hemolytic anemia (hemoglobin 71 g/L), elevated lactate dehydrogenase (3129 U/L), undetectable haptoglobin, and schistocytosis (up to 3.9%), accompanied by neurological symptoms, leading to the diagnosis of TA-TMA. Results: Management included discontinuation of tacrolimus, initiation of plasma exchange, and complement inhibition with eculizumab, along with ruxolitinib for graft-versus-host disease prophylaxis. This approach resulted in rapid clinical and laboratory improvement, including resolution of hemolysis, reduction in schistocytes (to 1%), normalization of lactate dehydrogenase, and regression of neurological symptoms. The patient was discharged in stable condition, although requiring ongoing renal replacement therapy. Conclusions: This case highlights the complexity of diagnosing and managing sequential endothelial complications after haplo-HSCT. SOS and TA-TMA may reflect overlapping manifestations of endothelial injury rather than entirely isolated complications.

17 April 2018 in Comparative Clinical Pathology
Verified
Journal Article
Closed access
PDF file
LLLina Lebedeva
Lina Lebedeva
KMKarakoz Tanatkyzy Mukhambetiyar
Karakoz Tanatkyzy Mukhambetiyar
MSMariya Suvorova
Mariya Suvorova